377 related articles for article (PubMed ID: 34388982)
1. Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
Meazza Prina M; Martini F; Bracchi F; Di Mauro D; Fargnoli A; Motta M; Giussani C; Gobbin G; Taverna M; D'Alessio A
BMC Infect Dis; 2021 Aug; 21(1):811. PubMed ID: 34388982
[TBL] [Abstract][Full Text] [Related]
2. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
Soy M; Atagündüz P; Atagündüz I; Sucak GT
Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
[TBL] [Abstract][Full Text] [Related]
3. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.
Yongzhi X
Emerg Microbes Infect; 2021 Dec; 10(1):266-276. PubMed ID: 33522893
[TBL] [Abstract][Full Text] [Related]
4. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients.
Lorenz G; Moog P; Bachmann Q; La Rosée P; Schneider H; Schlegl M; Spinner C; Heemann U; Schmid RM; Algül H; Lahmer T; Huber W; Schmaderer C
Sci Rep; 2020 Oct; 10(1):18277. PubMed ID: 33106497
[TBL] [Abstract][Full Text] [Related]
5. Haemophagocytic syndrome and COVID-19.
Retamozo S; Brito-Zerón P; Sisó-Almirall A; Flores-Chávez A; Soto-Cárdenas MJ; Ramos-Casals M
Clin Rheumatol; 2021 Apr; 40(4):1233-1244. PubMed ID: 33389315
[TBL] [Abstract][Full Text] [Related]
6. Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: A case series.
Hansen S; Alduaij W; Biggs CM; Belga S; Luecke K; Merkeley H; Chen LYC
Eur J Haematol; 2021 May; 106(5):654-661. PubMed ID: 33523540
[TBL] [Abstract][Full Text] [Related]
7. [Secondary hemophagocytic lymphohistiocytosis and cytokine release syndrome in COVID-19, the same or different entities?].
Alfaro-Murillo A; Lazo-Paéz G
Rev Chilena Infectol; 2021 Apr; 38(2):271-278. PubMed ID: 34184718
[TBL] [Abstract][Full Text] [Related]
8. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
Opoka-Winiarska V; Grywalska E; Roliński J
BMC Med; 2020 Jul; 18(1):214. PubMed ID: 32664932
[TBL] [Abstract][Full Text] [Related]
9. A case of Hemophagocytic lymphohistiocytosis induced by COVID-19, and review of all cases reported in the literature.
Kayaaslan BU; Asilturk D; Eser F; Korkmaz M; Kucuksahin O; Pamukcuoglu M; Guner R
J Infect Dev Ctries; 2021 Nov; 15(11):1607-1614. PubMed ID: 34898486
[TBL] [Abstract][Full Text] [Related]
10. Haemophagocytic lymphohistiocytosis in an adult with postacute COVID-19 syndrome.
Wiseman D; Lin J; Routy JP; Samoukovic G
BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34518190
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.
Meng M; Chen L; Zhang S; Dong X; Li W; Li R; Deng Y; Wang T; Xu Y; Liu J; Huang Y; Chen Y; Huang S; Wen Z; Zhang L; Du H; Liu Y; Annane D; Qu J; Chen D
BMC Infect Dis; 2021 Apr; 21(1):398. PubMed ID: 33926377
[TBL] [Abstract][Full Text] [Related]
12. Hemophagocytic histiocytosis in severe SARS-CoV-2 infection: A bone marrow study.
Dandu H; Yadav G; Malhotra HS; Pandey S; Sachu R; Dubey K
Int J Lab Hematol; 2021 Dec; 43(6):1291-1301. PubMed ID: 34086418
[TBL] [Abstract][Full Text] [Related]
13. Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers.
Kessel C; Vollenberg R; Masjosthusmann K; Hinze C; Wittkowski H; Debaugnies F; Nagant C; Corazza F; Vély F; Kaplanski G; Girard-Guyonvarc'h C; Gabay C; Schmidt H; Foell D; Tepasse PR
Arthritis Rheumatol; 2021 Oct; 73(10):1791-1799. PubMed ID: 33880885
[TBL] [Abstract][Full Text] [Related]
14. Hemophagocytic lymphohistiocytosis in COVID-19: Case reports of a stepwise approach.
Schnaubelt S; Tihanyi D; Strassl R; Schmidt R; Anders S; Laggner AN; Agis H; Domanovits H
Medicine (Baltimore); 2021 Mar; 100(12):e25170. PubMed ID: 33761694
[TBL] [Abstract][Full Text] [Related]
15. Secondary Hemophagocytic Lymphohistiocytosis in a Neonate with SARS-CoV-2 Infection.
El-Isa HZ; Khader OA; Khader M; Ashour BA; Azzam MI; Badran EF
Am J Case Rep; 2022 Jan; 23():e934839. PubMed ID: 35087017
[TBL] [Abstract][Full Text] [Related]
16. Sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) coinfected with COVID-19 complicated by hemophagocytic lymphohistiocytosis: a case report.
Li M; Li F; Dai Y; Zeng YZ; Chen X
Front Immunol; 2024; 15():1371490. PubMed ID: 38686382
[TBL] [Abstract][Full Text] [Related]
17. Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis?
Liu JM; Chi J
Exp Biol Med (Maywood); 2022 Feb; 247(4):330-337. PubMed ID: 35068219
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.
Prilutskiy A; Kritselis M; Shevtsov A; Yambayev I; Vadlamudi C; Zhao Q; Kataria Y; Sarosiek SR; Lerner A; Sloan JM; Quillen K; Burks EJ
Am J Clin Pathol; 2020 Sep; 154(4):466-474. PubMed ID: 32681166
[TBL] [Abstract][Full Text] [Related]
19. Secondary hemophagocytic lymphohistiocytosis versus cytokine release syndrome in severe COVID-19 patients.
Hakim NN; Chi J; Olazagasti C; Liu JM
Exp Biol Med (Maywood); 2021 Jan; 246(1):5-9. PubMed ID: 32972235
[TBL] [Abstract][Full Text] [Related]
20. Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis.
Chu R; van Eeden C; Suresh S; Sligl WI; Osman M; Cohen Tervaert JW
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
